News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Brown Advisory, an investment management company, released its "Brown Advisory Global Leaders Strategy" for the second quarter of 2026 investor letter. A copy of the letter can be downloaded here. Brown Advisory's Global Leaders Strategy delivered a net return of 4.6% in the second …
Sharemaestro market context Trend signal started 52 weeks -16.9% · Next-week setup negative 23.8%In recent trading, shares of Workday Inc (Symbol: WDAY) have crossed above the average analyst 12-month target price of $230.28, changing hands for $231.68/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on …
Sharemaestro market context Trend signal started 52 weeks -16.9% · Next-week setup negative 23.8%Arcadia Biosciences (RKDA) received a Nasdaq notice on August 4, 2026, indicating non-compliance with the $1.00 minimum bid price rule. The company's stock has traded below this threshold for 30 consecutive business days. Arcadia Biosciences has 180 days, until February 1, 2027, to regain …
This article details Hotchkis & Wiley Opportunities Fund's investment history in Workday Inc (WDAY). As of June 30, 2026, the fund held 32,422 shares valued at $7.42 million, representing 0.84% of its portfolio. The fund has made 9 purchases and 8 sales of WDAY …
This article provides current stock information for Arcadia Biosciences Inc (RKDA), showing its latest trading price and daily performance. It notes that more news and analysis for the company will be available soon. The page also includes general information about the company's financials, stock …
Arcadia Biosciences (RKDA) has received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement of $1.00 per share. The company's stock traded below this threshold for 30 consecutive business days, leading to potential delisting risk. RKDA has an initial 180-day period, …
This article provides an earnings forecast for Arcadia Biosciences Inc (RKDA), detailing its current stock price, market capitalization, and analyst ratings. Based on one analyst, the company has a "Buy" rating with a target price of $12.00, representing a significant upside. The report also …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Workday (WDAY) is back in focus after Antipodes Partners trimmed its position in the stock during Q2 2026. The fund cited concerns about AI pressure on Workday's …
Sharemaestro market context Trend signal started 52 weeks -16.9% · Next-week setup negative 23.8%The move matters because participation improved on a weekly active-mover scan even as technical evidence stayed mixed.
The cloud-software stock has regained ground, though the broader technical setup remains mixed.
Shares of Salesforce, HubSpot, Okta, Workday, and Datadog saw significant jumps, propelled by easing geopolitical tensions, lower Treasury yields, and increased AI-driven M&A activity within the software sector. The de-escalation of tensions and subsequent drop in interest rates are funneling capital back into growth-oriented …
The application-software stock produced its strongest recent weekly gain on above-average volume, yet Sharemaestro’s Trend Signal remains inactive and Relative Strength is still negative.
Arcadia Biosciences Inc (RKDA) currently holds a financial score of 6.21, ranking 76th out of 94 companies in the Food & Tobacco industry. The company's financial status is considered robust, but its operating efficiency is low. Its recent quarterly revenue was $1.10M, marking an …
Verdeca, a joint venture of Arcadia Biosciences and Bioceres Crop Solutions, has received USDA approval for its HB4 drought-tolerant soybeans, allowing for commercialization in the U.S. This follows FDA approval in 2017. The HB4 trait is now approved in over 80% of the global …
This article provides a comprehensive stock analysis of Arcadia Biosciences Inc (RKDA) from TradingKey. It highlights that RKDA has relatively healthy fundamentals and significant growth potential, although its valuation is considered fair within the Food & Tobacco industry. The stock is currently trading sideways, …
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 9.7% in Workday, Inc.'s Class A stock. This amounts to 19,580,021 shares, with BlackRock holding sole voting power over 18,111,849 shares and sole dispositive power over all 19,580,021 shares. The …
This article provides details on the institutional confidence score for Arcadia Biosciences Inc (RKDA), which stands at 3.00, unchanged from its previous score. It lists key institutional shareholders and their recent activity, including shares held and percentage change. The data highlights institutional investor holdings …
This article provides a detailed cash flow statement for Arcadia Biosciences Inc (RKDA), covering quarterly and annual data for operating, investing, and financing activities. It presents key financial figures, year-over-year changes, and includes an FAQ section explaining different types of cash flow and RKDA's …
This article provides a risk assessment for Arcadia Biosciences Inc (RKDA), noting its current risk score of 1.33, ranking 81 out of 93 in the Food & Tobacco industry. The company's beta of 0.51 suggests it is less volatile than the S&P 500. The …
This article provides a revenue breakdown for Arcadia Biosciences Inc (RKDA), highlighting its regional revenue contributions. While specific business segment data and profit contributions are not yet disclosed, the report shows the United States as a primary revenue source. This information is intended for …
Arcadia Biosciences, Inc. (FWB:17D) generated 4.14 million EUR in revenue last year, primarily from its Zola and Gamma Linolenic Acid Products segment. This figure is down from 4.84 million EUR in the previous year. The United States was the largest contributor to revenue, accounting …
This article presents the detailed balance sheet for Arcadia Biosciences Inc (RKDA), offering quarterly and annual financial data spanning several years. It allows investors to analyze the company's financial health, liquidity, leverage, and return on equity through various metrics like cash, total assets, liabilities, …
Morgan Stanley downgraded Workday (WDAY) to Underweight due to a sector shift towards infrastructure and cybersecurity, causing a 5.54% premarket drop. Despite the downgrade, Workday's Adaptive Planning received FedRAMP Moderate approval for government cloud use, and its AI tools promise significantly faster content creation.
This article details the shareholder structure of Arcadia Biosciences Inc (RKDA), highlighting its major shareholders and institutional holdings. It provides data on the proportion of shares held by various investment advisors, hedge funds, and individual investors, alongside a breakdown of institutional shareholding trends over …
This article provides historical data on dividends and stock splits for Arcadia Biosciences Inc (RKDA). It indicates that the company has not distributed any dividends over the past five years but shows a series of merger-related stock splits on February 28, 2023, with a …
This article provides an overview of Workday Inc. (WDAY), a leading provider of enterprise cloud applications, including financial and human capital management. It details the company's recent stock performance, highlighting its gains among market movers, and includes a compilation of recent articles and analyses …
This article examines how the recent OpenAI and Hugging Face security incident highlights the increasing cyber risks associated with AI, prompting investors to re-evaluate companies' exposure to these vulnerabilities. It focuses on three stocks—Workday (WDAY), AvePoint (AVPT), and BlackLine (BL)—detailing how each company is …
Search by ticker symbol or company name and select a result to open its chart.